Avita Medical Inc.
RCEL
NASDAQ·Healthcare·Medical - Devices·Mkt cap $278.2M
$11.20
▲ +2.38%
P/E
-7.78
Mkt Cap
$278.2M
52-Wk Range
$3.22–$11.39
52-Week Range
$3.22 - $11.39
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 166.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Patented autologous cell suspension technology using patient's own skin
- FDA-cleared RECELL System with established clinical efficacy in burn treatment
- Strategic research partnerships with leading medical institutions for pipeline expansion
- Proprietary spray-on delivery system enabling rapid, efficient cell application
Bear Case
1 risk
- High volatility (beta 2.0). Larger-than-normal price swings expected.
Growth
Moderate growth ahead
Expanding RECELL System adoption in acute burn care across multiple geographies
Value
Deep value opportunity - significant discount to Medical Devices peers
Momentum
Hot
+169.2% over 3m
Quality
Excellent
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying RCEL right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 6, 2026
Reported EPS of -$0.25 vs -$0.29 consensus (+14.6% surprise). Revenue of $21.5M vs $20.3M expected (+6.1%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+14.6%
Revenue trend · last 8Q
—
+30%
+67%
+21%
-13%
-4%
+4%
+18%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$19.5M
$18.4M
$18.5M
$18.4M
$17.1M
$17.6M
$19.3M
$21.7M
Margins · last 8Q
Gross
81.9%
Operating
93.5%
Profit
-35.3%
Wall Street consensus
4 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Lake Street · Aug 28, 2026
vs Industry
How RCEL stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related